HCID 86711984, compound → HCID 71002262, compound
Reaction equation
[CH:1]1([CH2:4][N:5]2[C:9]3[CH:10]=[CH:11][C:12]([C:16]4[CH:30]=[CH:29][C:19]([CH2:20][N:21]5[CH2:25][C:24](=[O:26])[N:23]([CH3:27])[C:22]5=[O:28])=[CH:18][CH:17]=4)=[C:13]([CH:14]=[CH2:15])[C:8]=3[N:7]=[N:6]2)[CH2:3][CH2:2]1>CCO.[Pd]>[CH:1]1([CH2:4][N:5]2[C:9]3[CH:10]=[CH:11][C:12]([C:16]4[CH:30]=[CH:29][C:19]([CH2:20][N:21]5[CH2:25][C:24](=[O:26])[N:23]([CH3:27])[C:22]5=[O:28])=[CH:18][CH:17]=4)=[C:13]([CH2:14][CH3:15])[C:8]=3[N:7]=[N:6]2)[CH2:3][CH2:2]1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 1-{4-[1-(cyclopropylmethyl)-4-ethenyl-1H-benzotriazol-5-yl]benzyl}-3-methylimidazolidine-2,4-dione (68 mg, 0.17 mmol) in EtOH (1.7 mL) was added palladium on carbon (10 wt %, 9 mg). The mixture was sparged under an atmosphere of hydrogen (1 atm) and stirred for 18 hours. The mixture was filtered through Celite and washed with ethanol. The filtrate was concentrated in vacuo and purified via reverse phase HPLC (5-95% MeCN/water+0.1% TFA) to provide the title compound: 1H NMR (400 MHz, CDCl3) 7.31-7.43 (m, 6H), 4.65 (s, 2H), 4.53 (d, 2H, J=6.8 Hz), 3.83 (s, 2H), 3.13 (q, 2H, J=7.6 Hz), 3.09 (s, 3H), 1.40-1.48 (m, 1H), 1.26 (t, 3H, J=7.2 Hz), 0.66-0.71 (m, 2H), 0.50-0.54 (m, 2H) ppm. LRMS m/z (M+H) 404.3 found, 404.2 required.
Workup
- customThe mixture was sparged under an atmosphere of hydrogen (1 atm)
- filtrationThe mixture was filtered through Celite
- washwashed with ethanol
- concentrationThe filtrate was concentrated in vacuo
- custompurified via reverse phase HPLC (5-95% MeCN/water+0.1% TFA)
Sources & evidence
- ORD record
- ord-be77931b669f43489114dcdb6388f467
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09139576B2
Reaction notes
Loading…